SynthesisJournal of global oncology2018

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.

Chia-Jui Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.